Package 11534-190-03

Brand: dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate

Generic: dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
NDC Package

Package Facts

Identity

Package NDC 11534-190-03
Digits Only 1153419003
Product NDC 11534-190
Description

1000 TABLET in 1 BOTTLE (11534-190-03)

Marketing

Marketing Status
Marketed Since 2018-07-04
Brand dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
Generic dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "86a00bec-51eb-4d73-a945-b1937970b29a", "openfda": {"upc": ["0311534193039", "0311534192032", "0311534191035", "0311534196016", "0311534190038", "0311534196030", "0311534195033"], "unii": ["O1ZPV620O4", "6DPV8NK46S", "G83415V073", "JJ768O327N"], "rxcui": ["541363", "541878", "541892", "577957", "577961", "687043", "1009145"], "spl_set_id": ["ac102599-3a5b-4154-899e-6ff262be7ff7"], "manufacturer_name": ["SUNRISE PHARMACEUTICAL, INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (11534-190-01)", "package_ndc": "11534-190-01", "marketing_start_date": "20180704"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (11534-190-03)", "package_ndc": "11534-190-03", "marketing_start_date": "20180704"}], "brand_name": "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE", "product_id": "11534-190_86a00bec-51eb-4d73-a945-b1937970b29a", "dosage_form": "TABLET", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]"], "product_ndc": "11534-190", "dea_schedule": "CII", "generic_name": "dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate", "labeler_name": "SUNRISE PHARMACEUTICAL, INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE", "active_ingredients": [{"name": "AMPHETAMINE ASPARTATE MONOHYDRATE", "strength": "1.25 mg/1"}, {"name": "AMPHETAMINE SULFATE", "strength": "1.25 mg/1"}, {"name": "DEXTROAMPHETAMINE SACCHARATE", "strength": "1.25 mg/1"}, {"name": "DEXTROAMPHETAMINE SULFATE", "strength": "1.25 mg/1"}], "application_number": "ANDA209799", "marketing_category": "ANDA", "marketing_start_date": "20180704", "listing_expiration_date": "20261231"}